CMP compumedics limited

Yep, FY23 Revenue & EBITDA forecast is a 10% increment with...

  1. 920 Posts.
    lightbulb Created with Sketch. 227
    Yep,

    FY23 Revenue & EBITDA forecast is a 10% increment with Revenue up to 40mil and EBITDA up of 4mil
    With management emphasizing the need to improve cash and profit margins.

    All these figures exclude the MEG sale to China and any other potential deal that may eventuate.

    One can assume that SP was beaten down and was exaggerated to the downside.
    It may take a bit of time for SP to recuperate but as market sentiment improve and a few positive news from the management (who received a wake-up call in the last few months in relation to the need of updating Shareholders.)

    Current M/Cap @ 42mil with 7mil in cash gives an EV of 35MIL a few million lower than its annual revenue
    with an EBITDA of 9 times to EV

    Lots of potentials and as usual lots more patience to see it climbing up
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.0¢
Change
0.005(1.75%)
Mkt cap ! $55.74M
Open High Low Value Volume
29.0¢ 29.0¢ 29.0¢ $2.465K 8.5K

Buyers (Bids)

No. Vol. Price($)
1 26600 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 20999 1
View Market Depth
Last trade - 11.51am 22/07/2025 (20 minute delay) ?
CMP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.